Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on ...
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
Eli Lilly is set to launch its popular weight-loss drug in emerging markets, including India, Brazil, and Mexico, by mid-2025 ...
After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...
Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
Zacks Investment Research on MSN10d
Lilly's Jaypirca Gets CHMP Nod for 2nd Leukemia Indication in EuropeEli Lilly and Company LLY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback